This inventor holds 1 USPTO granted patent. Top assignee: Tohoku University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations by Shunji Mugikura in Blood Vessel Generation
Introduction
Shunji Mugikura is a notable inventor based in Sendai, Japan. He has made significant contributions to the field of medical technology, particularly in the area of blood vessel generation. His innovative work has led to the development of a unique device that enhances the understanding and evaluation of blood vessels.
Latest Patents
Shunji Mugikura holds a patent for a standard blood vessel generation device, along with associated evaluation devices and programs. This invention specifies a blood vessel region in which a blood vessel is depicted in an image. It derives a feature line that connects feature points included in multiple figures within the blood vessel region. The device also identifies branch points on the feature line and disposes division points for line division. It executes a process of calculating a statistical amount of coordinates for the division points and sets a standard point based on these coordinates. The invention generates a standard blood vessel with a defined diameter at the standard point, which is crucial for medical applications.
Career Highlights
Shunji Mugikura is affiliated with Tohoku University, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on medical practices and technologies.
Collaborations
Shunji Mugikura collaborates with notable colleagues, including Hitomi Anzai and Makoto Ohta. Their combined expertise contributes to the advancement of research in blood vessel generation and evaluation.
Conclusion
Shunji Mugikura's innovative contributions to blood vessel technology exemplify the intersection of medical research and engineering. His patented inventions hold promise for improving medical procedures and patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
